Related Experiment Video

Updated: Jun 25, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Functional, structural, and genetic evaluation of 20 CDKN2A germ line mutations identified in melanoma-prone families

Caroline Kannengiesser1, Sharon Brookes, Anna Gutierrez del Arroyo

  • 1Service de Génétique, Institut Gustave Roussy, Villejuif, France.

Human Mutation
|March 5, 2009
PubMed

Insights

This study investigates 20 CDKN2A gene mutations linked to melanoma risk. Most mutations disrupt p16(INK4A) protein function, aiding in melanoma risk prediction for carriers.

Area of Science:

  • Genetics and Molecular Biology
  • Cancer Research
  • Human Genetics

Background:

  • Germline mutations in the CDKN2A gene are associated with hereditary melanoma.
  • The CDKN2A gene encodes the p16(INK4A) protein, a key regulator of cell cycle progression.
  • p16(INK4A) functions by inhibiting cyclin-dependent kinases CDK4 and CDK6.

Purpose of the Study:

  • To assess the pathogenicity of 20 previously uncharacterized CDKN2A germline mutations.
  • To determine the impact of these mutations on p16(INK4A) protein structure and function.
  • To improve melanoma risk assessment for individuals carrying CDKN2A variants.

Main Methods:

  • Analysis of genetic information for 20 CDKN2A germline mutations.
  • In silico prediction of the impact of variants on p16(INK4A) protein structure.
  • Experimental assessment of p16(INK4A) variants' interaction with CDK4 and their effect on cell proliferation.

Main Results:

  • Eighteen of the 20 investigated CDKN2A variants were classified as loss-of-function mutations.
  • The mutations were found to disrupt p16(INK4A) protein structure and its interaction with CDK4.
  • Two variants showed ambiguous results regarding their functional impact.

Conclusions:

  • The study identifies 18 loss-of-function CDKN2A mutations, contributing to the understanding of p16(INK4A) functional residues.
  • Accurate classification of CDKN2A variants is crucial for predicting melanoma risk in affected families.
  • This research provides valuable data for genetic counseling and personalized melanoma risk management.

More Related Videos

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma08:18

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma

Published on: September 8, 2021

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...